Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

被引：0
|
作者：
Tomo Nozawa [1 ]
Naomi Iwata [2 ]
Toru Igarashi [3 ]
Ichiro Kobayashi [4 ]
Shoji Ota [5 ]
Takako Yamada [5 ]
Etsuya Bando [5 ]
Katsuyoshi Habiro [5 ]
Syuji Takei [6 ]
机构：
[1] Yokohama City University Graduate School of Medicine,Department of Pediatrics
[2] Aichi Children’S Health and Medical Center,Department of Infection and Immunology
[3] Nippon Medical School,Department of Pediatrics
[4] KKR Sapporo Medical Center,Center for Pediatric Allergy and Rheumatology
[5] Bristol Myers Squibb,Faculty of Medicine, School of Health Sciences
[6] Kagoshima University,undefined
来源：
Pediatric Rheumatology | / 23卷 / 1期
关键词：
D O I：
10.1186/s12969-025-01077-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis
    Pardeo, Manuela
    Wang, Jianmei
    Ruperto, Nicolino
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Schneider, Rayfel
    Horneff, Gerd
    Huppertz, Hans-Iko
    Minden, Kirsten
    Onel, Karen
    Zemel, Lawrence
    Martin, Alan
    Kone-Paut, Isabelle
    Siamopoulou-Mavridou, Antigoni
    Silva, Clovis A.
    Porter-Brown, Benjamin
    Bharucha, Kamal N.
    Brunner, Hermine, I
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1117 - 1126
  • [42] Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials
    Mora, Johanna R.
    Wong, Robert
    Shaikh, Mehmooda
    Askelson, Margarita
    ACR OPEN RHEUMATOLOGY, 2022, 4 (02) : 177 - 186
  • [43] Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Okamoto, Nami
    Atsumi, Tatsuya
    Takagi, Michiaki
    Takahashi, Nobunori
    Takeuchi, Tsutomu
    Tamura, Naoto
    Nakajima, Atsuo
    Nakajima, Ayako
    Fujii, Takao
    Matsuno, Hiroaki
    Ishii, Taeko
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Minatoya, Machiko
    Tanaka, Yoshiya
    Kuwana, Masataka
    MODERN RHEUMATOLOGY, 2024,
  • [44] Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
    Brunner, Hermine I.
    Tzaribachev, Nikolay
    Cornejo, Gabriel Vega
    Joos, Rik
    Gervais, Elisabeth
    Cimaz, Rolando
    Calvo Penades, Inmaculada
    Cuttica, Ruben
    Lutz, Thomas
    Quartier, Pierre
    Gandhi, Yash
    Nys, Marleen
    Wong, Robert
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)
  • [45] Golimumab for Treatment of Polyarticular Juvenile Idiopathic Arthritis - Safety and Effectiveness Updates from a Comparative Study
    Zimmer, Angela
    Klein, Ariane
    Horneff, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1737 - 1739
  • [46] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: PHARMACOKINETICS, EFFICACY AND SAFETY
    Ruperto, Nicolino
    Lovell, Daniel J.
    Tzaribachev, Nikolay
    Vega-Cornejo, Gabriel
    Louw, Ingrid
    Berman, Alberto
    Calvo, Inmaculada
    Cuttica, Ruben
    Horneff, Gerd
    Avila-Zapata, Francisco
    Anton, Jordi
    Cimaz, Rolando
    Solau-Gervais, Elisabeth
    Joos, Rik
    Espada, Graciela
    Li, Xiaohui
    Nys, Marleen
    Wong, Robert
    Banerjee, Subhashis
    Brunner, Hermine I.
    Martini, Alberto
    RHEUMATOLOGY, 2017, 56 : 40 - 41
  • [47] Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
    Brunner, Hermine I.
    Ruperto, Nicolino
    Zuber, Zbigniew
    Cuttica, Ruben
    Keltsev, Vladimir
    Xavier, Ricardo M.
    Burgos-Vargas, Ruben
    Penades, Inmaculada Calvo
    Silverman, Earl D.
    Espada, Graciela
    Zavaler, Manuel Ferrandiz
    Kimura, Yukiko
    Duarte, Carolina
    Job-Deslandre, Chantal
    Joos, Rik
    Douglass, Wendy
    Wimalasundera, Sunethra
    Bharucha, Kamal N.
    Wells, Chris
    Lovell, Daniel J.
    Martini, Alberto
    de Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 530 - 541
  • [48] SAFETY AND EFFICACY OF TOCILIZUMAB IN METHOTREXATE-RESISTANT FORM OF POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: FACTORS ASSOCIATED WITH ACHIEVEMENT OF INACTIVE DISEASE STATUS
    Kostik, M. M.
    Chikova, I. A.
    Isupova, E. A.
    Masalova, V. V.
    Dubko, M. F.
    Likhacheva, T. S.
    Snegireva, L. S.
    Kalashnikova, O. V.
    Chasnyk, V. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 619 - 619
  • [49] Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis
    Billiau, An D.
    Loop, Michele
    Le, Phu-Quoc
    Berthet, Francoise
    Philippet, Pierre
    Kasran, Ahmad
    Wouters, Carine H.
    RHEUMATOLOGY, 2010, 49 (08) : 1550 - 1558
  • [50] Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan
    Yamazaki, Naoya
    Shimizu, Akiko
    Ozaki, Masahiko
    Hamada, Masahiro
    Takeuchi, Noriko
    Ito, Yuichiro
    Maekawa, Shinichiroh
    JOURNAL OF DERMATOLOGY, 2022, 49 (11): : 1096 - 1105
12345